[DOI] [PubMed] [Google Scholar] 22.Capozzi ME, Svendsen B, Encisco SE, Lewandowski SL, Martin MD, Lin H, Jaffe JL, Coch RW, Haldeman JM, MacDonald PE, Merrins MJ, DAlessio DA, Campbell JE
7 In patients who meet these criteria, the ADA preferably recommends use of a GLP-1 RA with proven cardiovascular benefit or an SGLT-2 inhibitor with proven cardiovascular benefit provided they have adequate kidney function
However, this is a specialized approach that requires careful medical supervision
IL-6 is increased in inflammatory conditions including exercise and obesity (59, 60)
Improved adherence through easier administration could address one of the core arguments that led to coverage removal
How Stress and Sleep Affect Your Weight